Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:05 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2233–2256 of 7,258 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: High-Risk Clear all

Conditions: High-grade Glioma, Diffuse Intrinsic Pontine Glioma
Interventions: Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells; Biological
Lead sponsor: University of Florida; Other
Eligibility: 4 Years to 30 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2045
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Cytomegalovirus, Organ Transplant, Kidney Transplant; Complications, Liver Transplant Complications, Simultaneous Liver-Kidney Transplantation; Complications
Interventions: Cytomegalovirus Immune Globulin Intravenous (Human) monthly for three months; Drug
Lead sponsor: Camille N. Kotton, MD; Other
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Boston, Massachusetts • Dallas, Texas

Conditions: Prostate Cancer
Interventions: BMS-986165, Degarelix; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 6
States / cities: Basking Ridge, New Jersey • Montvale, New Jersey • Commack, New York + 3 more

Conditions: Sarcopenia, Metabolic Disease, High Blood Pressure
Interventions: Energy Restriction; Other
Lead sponsor: Purdue University; Other
Eligibility: 35 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Prostate Cancer
Interventions: Suramin; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Male only
Enrollment: 390 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2008
U.S. locations: 26
States / cities: Chicago, Illinois • Urbana, Illinois • Cedar Rapids, Iowa + 19 more

Conditions: Asthma
Interventions: Supporting Asthma Management Behaviors in Aging Adults (SAMBA); Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 60 Years and older
Enrollment: 406 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 3
States / cities: New York, New York

Conditions: Human Immunodeficiency Virus
Interventions: emtricitabine/tenofovir, CBT-based counseling; Drug · Behavioral
Lead sponsor: James Egan; Other
Eligibility: 18 Years and older · Male only
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Boston, Massachusetts • Pittsburgh, Pennsylvania

Conditions: Hypovitaminosis D
Interventions: 100,000 IU cholecalciferol, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: One-Lung Ventilation
Interventions: PEEP level, Use of recruitment maneuvers; Procedure
Lead sponsor: Technische Universität Dresden; Other
Eligibility: 18 Years and older
Enrollment: 2,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 3
States / cities: Boston, Massachusetts • New York, New York • Cleveland, Ohio

Conditions: Myeloma
Interventions: Topotecan, Cyclophosphamide, Melphalan, Peripheral Blood Stem Cells; Drug · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Up to 70 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Breast Cancer
Interventions: omega-3 fatty acid; Dietary Supplement
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Premature Infants
Interventions: Standard Protein Diet, High Protein Diet; Dietary Supplement
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 14 Days and older
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pancreatic Cancer, Colo-rectal Cancer, Gastric Cancer, Esophageal Cancer, Bladder Cancer, Ovarian Cancer, Abdominal Surgery Complications
Interventions: Multidisciplinary Prehabilitation Program; Behavioral
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetes Mellitus, Type II
Interventions: Liraglutide, Insulin; Drug
Lead sponsor: Mountain Diabetes and Endocrine Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Asheville, North Carolina

Conditions: Influenza
Interventions: HD Vaccine, SD Vaccine, Free Vaccine, Usual Care; Biological
Lead sponsor: Insight Therapeutics, LLC; Other
Eligibility: 65 Years and older
Enrollment: 823 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 3
States / cities: Cleveland, Ohio • Providence, Rhode Island • Norfolk, Virginia

Conditions: Overweight, Obesity, Type 2 Diabetes
Interventions: High-MUFA diet, High-CHO diet; Other
Lead sponsor: University of Cincinnati; Other
Eligibility: 30 Years to 75 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Biochemical Recurrence (BCR), High-Risk Localized Prostate Cancer
Interventions: RYZ711, PSMA PET/CT; Drug · Diagnostic Test
Lead sponsor: RayzeBio, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Healthy
Interventions: Fiber cereal; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 70 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Stress (Psychology), Resilience, Psychological, Anxiety, Depressive Symptoms, Well-being, Sleep Quality
Interventions: Wearable ring with continuous biometric monitoring, AI health coaching application, Osteopathic manipulative treatment (OMT); Device · Behavioral · Other
Lead sponsor: Touro University, California; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Vallejo, California

Conditions: Fluid Accumulation, Blood Pressure Management, End Stage Renal Disease (ESRD)
Interventions: Ultrafiltration; Procedure
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Coronary Artery Disease
Interventions: High-risk percutaneous coronary intervention; Procedure
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Oropharynx Cancer, HPV-Related Carcinoma
Interventions: Radiation, Platinum based chemotherapy; Radiation · Drug
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Tuberculosis
Interventions: Rifapentine (RPT); Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 4
States / cities: San Diego, California • Baltimore, Maryland • Chapel Hill, North Carolina + 1 more

Conditions: Myelodysplastic Syndrome
Interventions: Clofarabine; Drug
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Buffalo, New York

Search by objective public record fields.

IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer

Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese Adults

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Supporting Asthma Management Behaviors in Aging Adults

Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV

High Dose Preoperative Cholecalciferol Supplementation and Perioperative Vitamin D Status

Protective Ventilation With High Versus Low PEEP During One-lung Ventilation for Thoracic Surgery

TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma

Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer

Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants

Prehabilitation in High-risk Oncologic Surgery

Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics

High-Dose Influenza Vaccine in Nursing Homes

Effect of High Monounsaturated Fat Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes

RYZ711 Diagnostic Platform Study

Whole Grain and Fiber Addition Study

High-Tech, High-Touch

Dry Weight Reduction Intervention Via Extra Ultrafiltration

Pressure-Volume Loop During High-Risk PCI

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer

Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults

Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients